April 2026
1. HARAGUCHI M, Miuma S, Nakao Y, Fukushima M, et al
   A Phase Angle Used as a Screening Tool for Malnutrition in Japanese Patients with Liver Cirrhosis.
   Intern Med. 2026 Apr 7. doi: 10.2169/internalmedicine.6677.
   

   >> Share

   
   January 2026
2. KITAO T, Tanaka T, Kubori M, Komoda Y, et al
   Evaluation of the Short-term Effect of Pemafibrate on Liver Fibrosis Biomarkers Stratified by FIB-4 Index in Patients with Type 2 Diabetes Mellitus and Hypertriglyceridemia.
   Intern Med. 2026;65:252-261.
   

   >> Share

   
   
3. TAKADA H, Tamaki N, Ochi H, Mori N, et al
   Sofosbuvir/Velpatasvir in Chronic Hepatitis C, Compensated and Decompensated Cirrhosis, and Retreatment Settings.
   Intern Med. 2026 Jan 2. doi: 10.2169/internalmedicine.6497.
   

   >> Share

   
   November 2025
4. SATO K, Saito A, Miyazaki T, Nakamichi K, et al
   A Case of Cerebellar-Onset Progressive Multifocal Leukoencephalopathy (PML) Associated with Hepatitis B-related Liver Cirrhosis.
   Intern Med. 2025 Nov 13. doi: 10.2169/internalmedicine.6263.
   

   >> Share

   
   
5. NISHIKAWA H, Nishikawa T, Fukuda A, Ushiro K, et al
   Impact of the FIB4 Index on Pre-sarcopenia in Patients with Metabolic-dysfunction Associated Steatotic Liver Disease.
   Intern Med. 2025;64:3078-3087.
   

   >> Share

   
   August 2025
6. MAMIZU H, Matsushima K, Kumagai M, Kuwana C, et al
   Autopsy of a Patient with Hepatic Pleural Effusion Complicated by Pleurisy Associated with Sjogren's Syndrome.
   Intern Med. 2025;64:2489-2493.
   

   >> Share

   
   
7. OKUBO S, Takaki A, Sato I, Adachi T, et al
   Clinical Variables That Predict Liver-related Events in Steatotic Liver Disease Diagnosed by a Liver Biopsy.
   Intern Med. 2025;64:2425-2432.
   

   >> Share

   
   July 2025
8. YOKOYAMA S, Honda T, Ishizu Y, Imai N, et al
   Utility of MELD 3.0 and MELD-Na in Predicting Long-term Mortality and Rebleeding After Endoscopic Hemostasis for Acute Variceal Hemorrhaging in Patients with Cirrhosis.
   Intern Med. 2025 Jul 10. doi: 10.2169/internalmedicine.5556.
   

   >> Share

   
   June 2025
9. KAWANAKA M, Nishino K, Kawada M, Ishii K, et al
   Predictors of Atherosclerotic Cardiovascular Disease Events in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease.
   Intern Med. 2025;64:1791-1798.
   

   >> Share

   
   May 2025
10. HIDAKA S, Hashiguchi M, Ijuin S, Muromachi K, et al
    A Case of Heyde Syndrome Complicated by Alcoholic Liver Cirrhosis in which Aortic Valve Stenosis Was Diagnosed due to Gastrointestinal Bleeding.
    Intern Med. 2025 May 22. doi: 10.2169/internalmedicine.5469.
    

    >> Share

    
    
11. SAIKI R, Katayama K, Akiyama E, Oda K, et al
    Latent Tubulointerstitial Nephritis with IgM-positive Plasma Cells Uncovered in a Case of IgA Nephropathy and Primary Biliary Cholangitis: Clinical and Histological Insights.
    Intern Med. 2025 May 15. doi: 10.2169/internalmedicine.5217.
    

    >> Share

    
    
12. ICHIKAWA T, Yamashima M, Yamamichi S, Koike M, et al
    Pemafibrate Reduced Liver Stiffness in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease Complicated with Hyperlipidemia and Liver Fibrosis with a Fibrosis-4 Index Above 1.3.
    Intern Med. 2025;64:1296-1302.
    

    >> Share

    
    April 2025
13. OEDA S, Inoue K, Isoda H, Hirai K, et al
    Survey on Awareness and Implementation Rate of Ultrasound Elastography and Attenuation Imaging.
    Intern Med. 2025;64:1143-1149.
    

    >> Share

    
    March 2025
14. HIRAOKA A, Namisaki T, Nakai M, Hara N, et al
    Relationship between daily physical activity and muscle cramping in elderly liver cirrhosis patients-A multicenter study.
    Intern Med. 2025 Mar 29. doi: 10.2169/internalmedicine.5189.
    

    >> Share

    
    
15. KUSUMI Y, Hasebe T, Hayashi M, Kamikokura Y, et al
    Hepatocellular Carcinoma Arising Adjacent to Antiphospholipid Syndrome-associated Hepatic Infarction in a Non-cirrhotic Liver.
    Intern Med. 2025 Mar 22. doi: 10.2169/internalmedicine.5081.
    

    >> Share

    
    January 2025
16. KURUMAZAKI M, Ogawa N, Kobayashi M, Ikejiri F, et al
    A Case of Severe Hypocalcemia During JAK1/2 Inhibitor Therapy for Myelofibrosis in a Patient with Liver Cirrhosis.
    Intern Med. 2025 Jan 15. doi: 10.2169/internalmedicine.4723.
    

    >> Share

    
    
17. TADOKORO T, Tani J, Sato Y, Yano R, et al
    Decompensated Cirrhosis with Hepatopulmonary Syndrome in a Patient with Interrupted Treatment for Hypopituitarism: A Case Report.
    Intern Med. 2025 Jan 3. doi: 10.2169/internalmedicine.4753.
    

    >> Share

    
    
18. AMANO K, Sano T, Ide T, Nakano D, et al
    The Effect of MAFLD on Hepatocarcinogenesis in HBeAg-negative Patients with Undetectable HBV-DNA under NA Therapy: A Multicenter Study.
    Intern Med. 2025;64:1133-1141.
    

    >> Share

    
    July 2024
19. KAMEZAKI H, Iwanaga T, Maeda T, Senoo J, et al
    A Comparison of the Effects of Alcohol Abstinence and Drinking Habit on the Survival of Patients with Alcohol-related Cirrhosis: A Retrospective Observational Study.
    Intern Med. 2024 Jul 18. doi: 10.2169/internalmedicine.4092.
    

    >> Share

    
    June 2024
20. SUEKI A, Kaya D, Nagamatsu S, Yamamoto C, et al
    A Case of Secondary Growth Hormone Deficiency that Developed into Cirrhosis after Several Years of Interrupted Growth Hormone Replacement Therapy.
    Intern Med. 2024 Jun 27. doi: 10.2169/internalmedicine.3896.
    

    >> Share

    
    April 2024
21. HARA Y, Yanagita T, Ishii K, Nakamura K, et al
    Portal Vein Thrombosis Caused by Miliary Tuberculosis.
    Intern Med. 2024;63:1181-1182.
    

    >> Share

    
    February 2024
22. HADANO Y
    Use of Blood Culture Bottles in the Diagnosis of Spontaneous Bacterial Peritonitis.
    Intern Med. 2024;63:465.
    

    >> Share

    
    October 2023
23. MIYAZAWA M, Yanagi M, Chiba T, Kido H, et al
    Post-allogeneic Hematopoietic Stem Cell Transplantation Portal Hypertension Not Associated with Liver Cirrhosis, Veno-occlusive Disease, or Graft-versus-host Disease: A Case Report.
    Intern Med. 2023 Oct 13. doi: 10.2169/internalmedicine.2489.
    

    >> Share

    
    May 2023
24. MITA E, Liu LJ, Shing D, Force L, et al
    Real-world Safety and Effectiveness of 24-week Sofosbuvir and Ribavirin Treatment in Patients Infected with Rare Chronic Hepatitis C Virus Genotypes 3, 4, 5, or 6 in Japan.
    Intern Med. 2023;62:1405-1414.
    

    >> Share

    
    April 2023
25. HAYAKAWA Y, Tamaki N, Nakanishi H, Kurosaki M, et al
    Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy.
    Intern Med. 2023;62:973-978.
    

    >> Share

    
    March 2023
26. KAINAGA M, Sasaki T, Kitamura M, Nakayama T, et al
    Inflammatory Myopathy Associated with Anti-mitochondrial Antibody-negative Primary Biliary Cholangitis Diagnosed by a Liver Biopsy.
    Intern Med. 2023;62:797-802.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share